Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company's UNiTi ACDF Implant System has received FDA 510(k) clearance as a Class II spinal intervertebral body fixation orthosis. It uses superelastic Nitinol to provide continual compression for spinal fusion procedures. Clinical results are not detailed in public sources but the device has been deemed substantially equivalent to predicate devices by the FDA.[7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pressio Spine.